Back to Markets
MBMicrobot Medical Inc

Microbot Medical Inc

MBOTNASDAQ NMS - GLOBAL MARKET
Health CareHealth Care

$2.03

+0.1000 (+5.18%)

As of 05/29/26 EDT · USD

Compare
Low: $1.60Current: $2.03High: $4.67

Key Statistics

Open

$1.94

Day High

$2.18

Day Low

$1.91

Prev. Close

$1.93

VolumeShares traded today.

3.50M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$136.34M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-7.34

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$4.67

52W LowLowest price over the past 52 weeks.

$1.60

50D MAAverage closing price over the last 50 trading days.

$2.20

200D MAAverage closing price over the last 200 trading days.

$2.47

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+14.0%

1M

-0.5%

6M

+8.0%

YTD

-3.8%

1Y

-20.1%

About

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

www.microbotmedical.com/

Company Facts

SectorHealth Care
IndustryHealth Care
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade MBOT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.